Investors of Orthofix Medical Stock May Have Legal Claims – OFIX
Investors of Orthofix Medical Stock Encouraged To Contact Kehoe Law Firm, P.C.
Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Orthofix Medical Inc. (“Orthofix” or the “Company”) (NASDAQ: OFIX).
INVESTORS OF ORTHOFIX STOCK ARE ENCOURAGED TO CLICK HERE TO CONTACT KEHOE LAW FIRM, P.C.
On September 12, 2023, Business Wire reported that Orthofix announced that it replaced its CEO, CFO and Chief Legal Officer “follow[ing] the unanimous decision by the [Orthofix] Board’s independent directors to terminate for cause Keith Valentine, John Bostjancic and Patrick Keran from those respective roles. The Board also requested that Mr. Valentine resign from the Board.”
The Company, according to Business Wire, also reported that “[t]he Board’s decision follows an investigation conducted by independent outside legal counsel and directed and overseen by the Company’s independent directors. As a result of the investigation, the Board determined that each of these executives engaged in repeated inappropriate and offensive conduct that violated multiple code of conduct requirements and was inconsistent with the Company’s values and culture.”
OFIX stock was down more than 19% in pre-market trading on September 12, 2023.
ORTHOFIX SHAREHOLDERS ARE ALSO ENCOURAGED TO CONTACT JOHN KEHOE, ESQ., (215) 792-6676, EXT. 801, [email protected], [email protected], TO LEARN MORE ABOUT THE ORTHOFIX SECURITIES INVESTIGATION AND POTENTIAL LEGAL CLAIMS.
